Rohin Patel

Item: Rohin Patel
Rating: 2.22
Author: StockAnalysis.com

Stock Analyst at JP Morgan

(2.22)

# 2,836

Out of 5,090 analysts

Total ratings

50%

Success rate

13.85%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Rohin Patel

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NPCE NeuroPace	Maintains: Overweight	$16 → $18	$16.40	+9.76%	1	Nov 5, 2025
	HAE Haemonetics	Downgrades: Neutral	$85 → $62	$83.94	-26.14%	2	Aug 8, 2025

NeuroPace

Nov 5, 2025

Maintains: Overweight

Price Target: $16 → $18

Current: $16.40

Upside: +9.76%

Haemonetics

Aug 8, 2025

Downgrades: Neutral

Price Target: $85 → $62

Current: $83.94

Upside: -26.14%